Özet:

Escitalopram (ESC) is a selective serotonin recovery inhibitor (SSGI), Citalopram's S-enantiomer, and has been effective in the treatment of major depressive disorders. A, β adrenergic, dopaminergic receptors and GABA and histamine receptors are very little or no affinity. Therefore, there are not too many side effects. It does not have a significant impact on the system P-450. The drug interactions are small. Among its side effects, the most common is headaches and impurities, the symptoms of the digestive system, insomnia, depression, tremor, turmoil, skin outbreak, tendance to bleeding can be seen. In our literature scan, there was not much of the outbreak occurring during treatment with ESC. The major depressive disorder (MDB) diagnosed in the bed and treated in our patient saw a swelling on the face, hands and legs during the ESC treatment. The fact is important to support that obesity may develop during treatment with ESC.

Anahtar Kelimeler: